Pharmaceutical / Drug Definition :
Competitively blocks postsynaptic (alpha1) and presynaptic (alpha2) adrenergic receptors. Acts on arterial tree and venous bed, reducing total peripheral resistance and lowering venous return to heart.
FDA Label Requirements and Exceptions
Phentolamine Mesylate
FDA Import Information
Phentolamine Mesylate
FDA Detentions
Phentolamine Mesylate (Phentolamine Mesylate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Phentolamine Mesylate (Phentolamine Mesylate Suppliers)
- Processors Phentolamine Mesylate
- Repackers Phentolamine Mesylate
- Relabelers Phentolamine Mesylate
- Exporters Phentolamine Mesylate
- Importers Phentolamine Mesylate
For more information about Phentolamine Mesylate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
